Atlas Trials

Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of Antiretroviral-Experienced NonCCR5-Tropic HIV-1 Infected Subjects

Clinical trial NCT00098748 · COMPLETED

Trial details

NCT number
NCT00098748
Sponsor
ViiV Healthcare
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
HIV Infections
Start date
2004-11-01
Primary completion
2005-12-01
Enrollment
190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.